Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.
Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for...
GLEN ALLEN, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
GLEN ALLEN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.08 | -7.27272727273 | 1.1 | 1.28 | 0.9924 | 524175 | 1.10836281 | CS |
4 | -0.08 | -7.27272727273 | 1.1 | 1.28 | 0.9696 | 200805 | 1.08378746 | CS |
12 | 0.05 | 5.15463917526 | 0.97 | 1.28 | 0.9355 | 145532 | 1.06105863 | CS |
26 | -0.46 | -31.0810810811 | 1.48 | 3 | 0.9 | 1470195 | 1.28192406 | CS |
52 | -1.1 | -51.8867924528 | 2.12 | 4.12 | 0.765 | 2383521 | 1.97512939 | CS |
156 | -73.98 | -98.64 | 75 | 78.5 | 0.765 | 1178483 | 6.21191391 | CS |
260 | -38.98 | -97.45 | 40 | 127 | 0.765 | 1020525 | 23.963201 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales